Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Makishima

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Leukemia Research|September 1, 1996
Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cellsM Makishima, Y Honma
Leukemia & Lymphoma|June 1, 1997
Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemiaM Makishima, Y Honma
Biochemical Pharmacology|February 10, 1999
Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cellsM Makishima, K Shudo, Y Honma
British Journal of Cancer|February 12, 1998
Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyureaM Makishima, J Okabe-Kado, Y Honma
Biochimica Et Biophysica Acta|December 12, 1995
19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cellsM Makishima, Y Yamamoto-Yamaguchi, Y Honma
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 14, 2001
Metabolic activation of bisphenol A by rat liver S9 fractionS Yoshihara, M Makishima, N Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1992
[Intensive carboquone and cryopreserved autologous bone marrow transplantation for relapsed malignancies]K Sampi, T Kuga, M Makishima, et al.
Blood|April 15, 1996
Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acidM Makishima, Y Kanatani, Y Yamamoto-Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1993
[Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3- nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation]K Sampi, M Makishima, T Kuga, et al.
Biochimica Et Biophysica Acta|April 16, 1993
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factorM Makishima, Y Honma, M Hozumi, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Leukemia Research|September 1, 1996
Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cellsM Makishima, Y Honma
Leukemia & Lymphoma|June 1, 1997
Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemiaM Makishima, Y Honma
Biochemical Pharmacology|February 10, 1999
Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cellsM Makishima, K Shudo, Y Honma
British Journal of Cancer|February 12, 1998
Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyureaM Makishima, J Okabe-Kado, Y Honma
Biochimica Et Biophysica Acta|December 12, 1995
19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cellsM Makishima, Y Yamamoto-Yamaguchi, Y Honma
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 14, 2001
Metabolic activation of bisphenol A by rat liver S9 fractionS Yoshihara, M Makishima, N Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1992
[Intensive carboquone and cryopreserved autologous bone marrow transplantation for relapsed malignancies]K Sampi, T Kuga, M Makishima, et al.
Blood|April 15, 1996
Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acidM Makishima, Y Kanatani, Y Yamamoto-Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1993
[Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3- nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation]K Sampi, M Makishima, T Kuga, et al.
Biochimica Et Biophysica Acta|April 16, 1993
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factorM Makishima, Y Honma, M Hozumi, et al.
Pageof 3